{"id":"https://openalex.org/W4361817458","doi":"https://doi.org/10.1158/1078-0432.c.6519096","title":"Data from Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment","display_name":"Data from Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361817458","doi":"https://doi.org/10.1158/1078-0432.c.6519096"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6519096","doi":"https://doi.org/10.1158/1078-0432.c.6519096","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519096","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6519096","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080827385","display_name":"Higinio Dopeso","orcid":"https://orcid.org/0000-0003-0060-1861","observed_orcids":["https://orcid.org/0000-0003-0060-1861"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Higinio Dopeso","raw_affiliation_strings":["Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090975645","display_name":"Silvia Mateo\u2010Lozano","orcid":"https://orcid.org/0000-0002-2365-1573","observed_orcids":["https://orcid.org/0000-0002-2365-1573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Mateo-Lozano","raw_affiliation_strings":["Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030657436","display_name":"Elena \u00c9lez","orcid":"https://orcid.org/0000-0002-4653-6324","observed_orcids":["https://orcid.org/0000-0002-4653-6324","https://orcid.org/0000-0002-9178-0246"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Elez","raw_affiliation_strings":["Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079339385","display_name":"Stefania Landolfi","orcid":"https://orcid.org/0000-0002-1059-635X","observed_orcids":["https://orcid.org/0000-0002-1059-635X"]},"institutions":[{"id":"https://openalex.org/I4210151726","display_name":"CIBBIM-Nanomedicine","ror":"https://ror.org/04xezgr31","country_code":"ES","type":"other","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210102407","https://openalex.org/I4210127641","https://openalex.org/I4210151726","https://openalex.org/I4210153292","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Stefania Landolfi","raw_affiliation_strings":["Group of Molecular Oncology,","Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Group of Molecular Oncology,","institution_ids":[]},{"raw_affiliation_string":"Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4210151726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058910780","display_name":"Francisco Javier Ramos","orcid":"https://orcid.org/0000-0002-0918-5895","observed_orcids":["https://orcid.org/0000-0002-0918-5895"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco Javier Ramos Pascual","raw_affiliation_strings":["Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028282340","display_name":"Javier Hern\u00e1ndez\u2010Losa","orcid":"https://orcid.org/0000-0003-1526-3201","observed_orcids":["https://orcid.org/0000-0003-1526-3201"]},"institutions":[{"id":"https://openalex.org/I4210151726","display_name":"CIBBIM-Nanomedicine","ror":"https://ror.org/04xezgr31","country_code":"ES","type":"other","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210102407","https://openalex.org/I4210127641","https://openalex.org/I4210151726","https://openalex.org/I4210153292","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Hern\u00e1ndez-Losa","raw_affiliation_strings":["Group of Molecular Oncology,","Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Group of Molecular Oncology,","institution_ids":[]},{"raw_affiliation_string":"Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4210151726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063055152","display_name":"Rocco Mazzolini","orcid":"https://orcid.org/0000-0003-3249-8387","observed_orcids":["https://orcid.org/0000-0003-3249-8387"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rocco Mazzolini","raw_affiliation_strings":["Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089999973","display_name":"Paulo Rodrigues","orcid":"https://orcid.org/0000-0002-5380-2715","observed_orcids":["https://orcid.org/0000-0002-5380-2715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paulo Rodrigues","raw_affiliation_strings":["Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070925260","display_name":"Sarah Bazzocco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Bazzocco","raw_affiliation_strings":["Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069165339","display_name":"Mar\u00eda Josep Carreras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Josep Carreras","raw_affiliation_strings":["Pharmacy, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082214696","display_name":"Eloy Esp\u00edn","orcid":"https://orcid.org/0000-0002-9139-4548","observed_orcids":["https://orcid.org/0000-0002-9139-4548","https://orcid.org/0000-0003-3784-1359"]},"institutions":[{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eloy Esp\u00edn","raw_affiliation_strings":["CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","Surgery, Vall d'Hebron Hospital, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","institution_ids":["https://openalex.org/I4210105141"]},{"raw_affiliation_string":"Surgery, Vall d'Hebron Hospital, and","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023092145","display_name":"Manel Armengol","orcid":"https://orcid.org/0000-0002-3211-3195","observed_orcids":["https://orcid.org/0000-0002-3211-3195"]},"institutions":[{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manel Armengol","raw_affiliation_strings":["CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","Surgery, Vall d'Hebron Hospital, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","institution_ids":["https://openalex.org/I4210105141"]},{"raw_affiliation_string":"Surgery, Vall d'Hebron Hospital, and","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew J. Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Wilson","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville; and","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038419173","display_name":"John M. Mariadason","orcid":"https://orcid.org/0000-0001-9123-7684","observed_orcids":["https://orcid.org/0000-0001-9123-7684"]},"institutions":[{"id":"https://openalex.org/I4210123010","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02vh2pt65","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210123010","https://openalex.org/I4210150094"]},{"id":"https://openalex.org/I4210163497","display_name":"Austin Health","ror":"https://ror.org/05dbj6g52","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210163497"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John M. Mariadason","raw_affiliation_strings":["Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia","institution_ids":["https://openalex.org/I4210123010","https://openalex.org/I4210163497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088341849","display_name":"Santiago Ram\u00f3n y Cajal","orcid":"https://orcid.org/0000-0002-3867-1390","observed_orcids":["https://orcid.org/0000-0002-3867-1390"]},"institutions":[{"id":"https://openalex.org/I4210151726","display_name":"CIBBIM-Nanomedicine","ror":"https://ror.org/04xezgr31","country_code":"ES","type":"other","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210102407","https://openalex.org/I4210127641","https://openalex.org/I4210151726","https://openalex.org/I4210153292","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Santiago Ramon y Cajal","raw_affiliation_strings":["Group of Molecular Oncology,","Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Group of Molecular Oncology,","institution_ids":[]},{"raw_affiliation_string":"Molecular Biology and Biochemistry Research Center, CIBBIM-Nano-medicine, Vall d'Hebron Hospital Research Institute, Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4210151726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190461","display_name":"Josep M. Tabernero","orcid":"https://orcid.org/0000-0002-2495-8139","observed_orcids":["https://orcid.org/0000-0002-2495-8139"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep Tabernero","raw_affiliation_strings":["Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012306555","display_name":"Sim\u00f3 Schwartz","orcid":"https://orcid.org/0000-0001-8297-7971","observed_orcids":["https://orcid.org/0000-0001-8297-7971"]},"institutions":[{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]},{"id":"https://openalex.org/I4210151726","display_name":"CIBBIM-Nanomedicine","ror":"https://ror.org/04xezgr31","country_code":"ES","type":"other","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210102407","https://openalex.org/I4210127641","https://openalex.org/I4210151726","https://openalex.org/I4210153292","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Simo Schwartz","raw_affiliation_strings":["CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","Drug Delivery and Targeting, Molecular Biology and Biochemistry Research Center (CIBBIM-Nanomedicine), Departments of 3 Pathology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","institution_ids":["https://openalex.org/I4210105141"]},{"raw_affiliation_string":"Drug Delivery and Targeting, Molecular Biology and Biochemistry Research Center (CIBBIM-Nanomedicine), Departments of 3 Pathology,","institution_ids":["https://openalex.org/I4210151726"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074768819","display_name":"Diego Arango","orcid":"https://orcid.org/0000-0003-2953-3284","observed_orcids":["https://orcid.org/0000-0003-2953-3284"]},"institutions":[{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Diego Arango","raw_affiliation_strings":["CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","Molecular Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain;","institution_ids":["https://openalex.org/I4210105141"]},{"raw_affiliation_string":"Molecular Oncology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5074768819"],"corresponding_institution_ids":["https://openalex.org/I4210105141"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.14589999616146088,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aprataxin","display_name":"aprataxin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9599999785423279},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.746999979019165},{"id":"https://openalex.org/keywords/camptothecin-sensitivity","display_name":"camptothecin sensitivity","score":0.9010000228881836},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.9309999942779541},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5870000123977661},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.5809999704360962},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.640999972820282},{"id":"https://openalex.org/keywords/tumor-gene-expression","display_name":"cancer gene expression","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.9774013161659241},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7511694431304932},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.6786938905715942},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.5558192729949951},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4755518138408661},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47507041692733765},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4694271683692932},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.45333629846572876},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3756125271320343},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2998618483543396},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25261300802230835},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0951949954032898},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07402190566062927}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6519096","doi":"https://doi.org/10.1158/1078-0432.c.6519096","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519096","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6519096.v1","doi":"https://doi.org/10.1158/1078-0432.c.6519096.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6519096.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6519096","doi":"https://doi.org/10.1158/1078-0432.c.6519096","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519096","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320325","display_name":"University of Sussex","ror":"https://ror.org/00ayhx656"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1536477417","https://openalex.org/W1536538430","https://openalex.org/W1745187809","https://openalex.org/W1912177776","https://openalex.org/W1965372133","https://openalex.org/W2033525264","https://openalex.org/W2069298164","https://openalex.org/W2095349399","https://openalex.org/W2097078602","https://openalex.org/W2099620553","https://openalex.org/W2109689528","https://openalex.org/W2110049076","https://openalex.org/W2112055293","https://openalex.org/W2128447158","https://openalex.org/W2136055188","https://openalex.org/W2142564546","https://openalex.org/W2145647042","https://openalex.org/W2148953497","https://openalex.org/W2152423165","https://openalex.org/W2152773775","https://openalex.org/W2157769714","https://openalex.org/W2159848047","https://openalex.org/W2168086106","https://openalex.org/W2325087121","https://openalex.org/W2330742770","https://openalex.org/W4255483444","https://openalex.org/W4382359689"],"related_works":["https://openalex.org/W2157759121","https://openalex.org/W4300887963","https://openalex.org/W2062903623","https://openalex.org/W4361942938","https://openalex.org/W1845202093","https://openalex.org/W7019706226","https://openalex.org/W1986104547","https://openalex.org/W1834650581","https://openalex.org/W2114133306","https://openalex.org/W258536826"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Irinotecan":[2],"(CPT11)":[3],"treatment":[4,19,168,186,263],"significantly":[5],"improves":[6],"the":[7,18,55,103,134,167,176],"survival":[8,207],"of":[9,20,35,53,57,71,74,89,105,169,175,179,252],"colorectal":[10,76,171],"cancer":[11,77],"patients":[12,36,58,162,216,248],"and":[13,43,80,84,102,188,205,229],"is":[14,45],"routinely":[15],"used":[16,68,144,245],"for":[17,48,166],"these":[21],"patients,":[22],"alone":[23],"or":[24,232],"in":[25,115,122,126,267],"combination":[26],"with":[27,185,192,217,249,264],"other":[28],"agents.":[29],"However,":[30],"only":[31],"20%":[32],"to":[33,41,62,82,91,137,145,149,246,254,261,270],"30%":[34],"show":[37,129,238],"an":[38,120,268],"objective":[39],"response":[40,90,148,187,253],"irinotecan,":[42],"there":[44],"great":[46],"need":[47],"new":[49,87],"molecular":[50],"markers":[51],"capable":[52],"identifying":[54],"subset":[56],"who":[59,257],"are":[60,258],"unlikely":[61],"respond.":[63],"Experimental":[64],"Design:":[65],"Here":[66],"we":[67,128],"microarray":[69,155],"analysis":[70],"a":[72,86,108,153,182],"panel":[73],"30":[75],"cell":[78],"lines":[79],"immunohistochemistry":[81],"identify":[83,247],"validate":[85],"biomarker":[88],"irinotecan.":[92,150],"Results:":[93],"A":[94],"good":[95],"correlation":[96],"was":[97],"observed":[98],"between":[99,225],"irinotecan":[100,165],"sensitivity":[101,136],"expression":[104],"aprataxin":[106,131,180,194,230,240],"(APTX),":[107],"histidine":[109],"triad":[110],"domain":[111],"superfamily":[112],"protein":[113],"involved":[114],"DNA":[116],"repair.":[117],"Moreover,":[118],"using":[119],"isogenic":[121],"vitro":[123],"system":[124],"deficient":[125],"APTX,":[127],"that":[130,140,163,239],"directly":[132],"regulates":[133],"cellular":[135],"camptothecin,":[138],"suggesting":[139],"it":[141],"could":[142],"be":[143,244],"predict":[146],"patient":[147,189,272],"We":[151],"constructed":[152],"tissue":[154],"containing":[156],"duplicate":[157],"tumor":[158,177,219,241],"samples":[159],"from":[160],"135":[161],"received":[164],"advanced":[170],"cancer.":[172],"Immunohistochemical":[173],"assessment":[174],"levels":[178,231,242],"showed":[181],"significant":[183],"association":[184],"survival.":[190,273],"Patients":[191],"low":[193,250],"had":[195],"longer":[196],"progression-free":[197],"(9.2":[198],"versus":[199,209],"5.5":[200],"months;":[201,211],"P":[202,212],"=":[203,213],"0.03)":[204],"overall":[206],"(36.7":[208],"19.0":[210],"0.008)":[214],"than":[215],"high":[218],"aprataxin.":[220],"No":[221],"associations":[222],"were":[223],"found":[224],"coding":[226],"APTX":[227],"variants":[228],"camptothecin":[233],"sensitivity.":[234],"Conclusions:":[235],"These":[236],"results":[237],"can":[243],"probability":[251],"irinotecan-based":[255],"therapy":[256],"ideal":[259],"candidates":[260],"receive":[262],"alternative":[265],"agents":[266],"attempt":[269],"improve":[271],"Clin":[274],"Cancer":[275],"Res;":[276],"16(8);":[277],"2375\u201382.":[278],"\u00a92010":[279],"AACR.":[280]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}